L

Ligand Pharmaceuticals
D

LGND

101.730
USD
0.43
(0.42%)
مغلق
حجم التداول
4,547
الربح لكل سهم
6
العائد الربحي
-
P/E
-14
حجم السوق
1,962,795,711
أصول ذات صلة
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
E
EXEL
-0.480
(-1.12%)
42.380 USD
INCY
INCY
-0.250
(-0.39%)
64.250 USD
LLY
LLY
-7.85
(-1.09%)
713.61 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
N
NKTR
0.00400
(0.62%)
0.64810 USD
REGN
REGN
-8.04
(-1.35%)
588.61 USD
المزيد
الأخبار المقالات

العنوان: Ligand Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.